Martin Brenner

Verkställande Direktör på IBIO, INC.

Förmögenhet: 58 239 $ per 2026-05-31

56 år

Health Technology

Consumer Services

Profil

Martin B. Brenner currently works at iBio, Inc., as Director, Chief Executive & Scientific Officer from 2024.
Dr. Brenner also formerly worked at AstraZeneca PLC, as Senior Director & Head-BioScience from 2012 to 2013, Merck Research Laboratories Massachusetts LLC, as Executive Director-Diabetes & NASH from 2013 to 2016, Recursion Pharmaceuticals, Inc., as Chief Scientific Officer from 2017 to 2018, Pelican, Inc., as Chief Scientific Officer & Senior Vice President from 2019 to 2020, Stoke Therapeutics, Inc., as VP & Head-Research & Early Development from 2016 to 2017, and Pfizer Inc., as Head-Insulin Resistance Group.
Dr. Brenner received his doctorate degree from Ludwig-Maximilians-Universität München and doctorate degree from The University of Veterinary Medicine Hanover.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
IBIO, INC. 0,09 %	2026-03-19	30 652 ( 0,09 % )	58 239 $	2026-05-31

Aktiva positioner av Martin Brenner

Företag	Position	Start
IBIO, INC.	Verkställande Direktör	2023-01-20

Alla aktiva positioner av Martin Brenner

Tidigare kända positioner av Martin Brenner

Företag	Position	Slut
PFENEX INC.	Teknisk/Vetenskaplig/F&U Direktör	2020-10-01
RECURSION PHARMACEUTICALS, INC.	Teknisk/Vetenskaplig/F&U Direktör	2018-01-01
STOKE THERAPEUTICS, INC.	Företagsledare/Principal	2017-01-01
Merck Research Laboratories Massachusetts LLC Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products	Direktör/Styrelseledamot	2016-01-01
ASTRAZENECA PLC	Företagsledare/Principal	2013-01-01

Se detaljerna i Martin Brenners erfarenhet

Martin Brenners utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Martin Brenners erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	9
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
AstraZeneca PLC AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Recursion Pharmaceuticals, Inc. Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery	Health Technology
Ludwig-Maximilians-Universität München Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Merck Research Laboratories Massachusetts LLC Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products	Health Technology
iBio, Inc. iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins	Health Technology
Pelican Inc Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines	Health Technology
The University of Veterinary Medicine Hanover The University of Veterinary Medicine Hanover Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stoke Therapeutics, Inc. Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases	Health Technology